preloader-icon-85
talia-left
talia-right

Alzheimer`s throughout the years

1906: Dr. Alois Alzheimer identifies the first case of what will later be known as Alzheimer's disease in a patient named Auguste Deter.

1970s: The first clinical trials for drugs to treat Alzheimer's disease begin, although it will be many years before an effective treatment is found.

1983: The Alzheimer's Association is founded in the United States, becoming the leading non-profit organization dedicated to funding Alzheimer's research and providing support to patients and caregivers.

1993: The FDA approves the drug tacrine, the first medication specifically designed to treat symptoms of Alzheimer's disease.

2006: The first international guidelines for diagnosing and treating Alzheimer's disease are published, helping to standardize care and improve outcomes for patients.

2011: The FDA approves the drug memantine, the first medication approved specifically for moderate to severe cases of Alzheimer's disease.

2015: President Barack Obama signs the National Alzheimer's Project Act into law, creating a national plan to address Alzheimer's disease and other forms of dementia.

2019: Biogen announces positive results from a clinical trial of a drug called aducanumab, which could become the first medication to slow the progression of Alzheimer's disease.

What is Alzheimer`s disease?

– Alzheimer’s disease is a progressive brain disorder that causes memory loss, cognitive decline, and other changes in behavior and personality.

– It is the most common form of dementia, accounting for 60-80% of all dementia cases.

– There is currently no cure for Alzheimer’s disease, but there are treatments that can help manage symptoms and slow its progression.

Facts and Figures:

– More than 6 million people in the United States have Alzheimer’s disease, and that number is expected to nearly triple by 2050.

– Alzheimer’s disease is the 6th leading cause of death in the United States.

– Women are more likely to develop Alzheimer’s disease than men, and African Americans and Hispanics are more likely to develop it than non-Hispanic whites.

– The economic impact of Alzheimer’s disease is enormous, with an estimated cost of $355 billion in the United States alone in 2021.

Early detection is crucial

Early detection of Alzheimer’s disease is crucial to improving patient outcomes and delaying the onset of more severe symptoms. Our Talia device uses innovative technology to detect Alzheimer’s disease in the early stages with accuracy and precision, providing patients with access to early intervention and treatment options.

It`s impact on people and healthcare

Early detection of Alzheimer’s disease can have a significant impact on the healthcare industry and the broader economy, reducing healthcare costs and improving productivity. By detecting Alzheimer’s disease early, we can also help to reduce the emotional and financial burden on patients and their families, improving quality of life for all involved.

How it affects patients & caregivers

The emotional and financial impact of Alzheimer’s disease is significant. According to the Alzheimer’s Association, more than 6 million Americans are living with Alzheimer’s disease, and this number is expected to increase in the coming years. The burden of caring for a loved one with Alzheimer’s disease is often overwhelming, both emotionally and financially. By detecting Alzheimer’s disease early, we can help to reduce the emotional and financial burden on patients and their families.

Early detection is crucial

Imagine being able to diagnose Alzheimer’s disease before it progresses to a severe stage. With our Talia device, you can. Our technology detects Alzheimer’s disease in the early stages with precision and accuracy. By providing patients with access to early intervention and treatment options, we can help to slow the progression of the disease and improve patient outcomes.

Improve Outcomes with Timely Intervention

At Talia, we believe that early detection of Alzheimer’s disease is crucial for improving patient outcomes, reducing healthcare costs, and improving the lives of those affected by this devastating condition. We are committed to providing patients, doctors, and the general population with access to cutting-edge technology for the early detection of Alzheimer’s disease. Contact us today to learn more about how Talia can benefit you and your loved ones.

TALIA

About

At Basil Health, we are committed to advancing healthcare through innovation and cutting-edge technology. We invite you to explore our solutions and discover how we can help you achieve your healthcare and research goals.

Products

Follow Us

Copyright, Basil Health